Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide, ranging from steatosis to non-alcoholic steatohepatitis (NASH). Recently, cerium oxide nanoparticles (CeO(2)NPs) have emerged as a new antioxidant agent with hepatoprotective properties in experime...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Sci Rep
Egile Nagusiak: Carvajal, Silvia, Perramón, Meritxell, Oró, Denise, Casals, Eudald, Fernández-Varo, Guillermo, Casals, Gregori, Parra, Marina, González de la Presa, Bernardino, Ribera, Jordi, Pastor, Óscar, Morales-Ruíz, Manuel, Puntes, Víctor, Jiménez, Wladimiro
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group UK 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6731222/
https://ncbi.nlm.nih.gov/pubmed/31492960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-49262-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak